Mark C. Levy, a Partner and Co-Chair of the Life Sciences Practice Group, is editor and a co-author of this Food and Drug Law Institute publication that provides comprehensive, practical advice on regulations proposed by the Food and Drug Administration governing the use of off-label promotions.
Bruce D. Armon, a Partner in the Life Sciences Practice Group, also co-authored chapters of the book.
For more information including how to purchase this book, please click here.